NCT03031288

Brief Summary

Aim of the study is to evaluate the effects of vented base bottles on respiration-swallow patterns and on gastroesophageal refluxes in preterm infants with clinical suspect of gastroesophageal reflux disease (GERD). In this crossover-randomized study, we compared the effects of standard feeding bottles (A) versus vented base feeding bottles (B) on a group of patients with at least 2 clinical GERD symptoms. 24 hours of synchronized cardiorespiratory (CR) and Esophageal Multichannel intraluminal impedance (MII/pH) monitoring were evaluated for each patient. During this period, patients were fed alternatively with feeding bottle A and B.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 12, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 25, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

March 31, 2020

Status Verified

March 1, 2020

Enrollment Period

1.9 years

First QC Date

January 12, 2017

Last Update Submit

March 27, 2020

Conditions

Keywords

gastroesophageal refluxswallowfeeding bottlecardiorespiratoryapnoeapretermimpedance-pH-metry

Outcome Measures

Primary Outcomes (1)

  • Frequency of cardiorespiratory events (feeding+postprandial time)

    Cardiorespiratory events / hour * apnea (no breathing movement for at least 20 s, or less if associated with desaturation/bradycardia) * desaturation (SpO2 \<80%) * bradycardia (heart rate \< 80 bpm for at least 1 s)

    calculated throughout 24 hour

Secondary Outcomes (2)

  • Swallow event characteristics (feeding time)

    calculated throughout 30 minute interval after the beginning of the milk meal

  • Frequency of reflux events (postprandial time)

    calculated throughout 150 minute interval after the end of the milk meal

Study Arms (2)

Start feeding with Device A, "standard"

EXPERIMENTAL

Alternatively feeding with standard feeding bottle (Device A) and vented base feeding bottle (Device B)

Device: ADevice: B

Start feeding with Device B, "vented"

EXPERIMENTAL

Alternatively feeding with vented base feeding bottle (Device B) and standard feeding bottle (Device A)

Device: ADevice: B

Interventions

ADEVICE

standard bottle

Start feeding with Device A, "standard"Start feeding with Device B, "vented"
BDEVICE

vented base bottle

Start feeding with Device A, "standard"Start feeding with Device B, "vented"

Eligibility Criteria

Age1 Week - 3 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • weight ≥ 1500 g at the time of examination
  • at least 2 GERD symptoms
  • exclusive enteral feeding
  • parents' informed consent

You may not qualify if:

  • congenital abnormalities
  • perinatal asphyxia
  • respiratory, genetic, metabolic, infectious and/or neurologic disease
  • pharmacological therapies, in the last 7 days, able to affect esophageal motility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ospedale S.Anna di Torino

Torino, (TO), 10126, Italy

Location

MeSH Terms

Conditions

Gastroesophageal RefluxBottle FeedingApneaPremature Birth

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesFeeding BehaviorBehaviorRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Francesco Cresi, MD PhD

    University of Turin, Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD

Study Record Dates

First Submitted

January 12, 2017

First Posted

January 25, 2017

Study Start

January 1, 2017

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

March 31, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations